Multiple Loci within the major histocompatibility complex confer risk of psoriasis.
Psoriasis is a common inflammatory skin disease characterized by thickened scaly red plaques. Previously we have performed a genome-wide association study (GWAS) on psoriasis with 1,359 cases and 1,400 controls, which were genotyped for 447,249 SNPs. The most significant finding was for SNP rs12191877, which is in tight linkage disequilibrium with HLA-Cw*0602, the consensus risk allele for psoriasis. However, it is not known whether there are other psoriasis loci within the MHC in addition to HLA-C. In the present study, we searched for additional susceptibility loci within the human leukocyte antigen (HLA) region through in-depth analyses of the GWAS data; then, we followed up our findings in an independent Han Chinese 1,139 psoriasis cases and 1,132 controls. Using the phased CEPH dataset as a reference, we imputed the HLA-Cw*0602 in all samples with high accuracy. The association of the imputed HLA-Cw*0602 dosage with disease was much stronger than that of the most significantly associated SNP, rs12191877. Adjusting for HLA-Cw*0602, there were two remaining association signals: one demonstrated by rs2073048 (p = 2 x 10(-6), OR = 0.66), located within c6orf10, a potential downstream effecter of TNF-alpha, and one indicated by rs13437088 (p = 9 x 10(-6), OR = 1.3), located 30 kb centromeric of HLA-B and 16 kb telomeric of MICA. When HLA-Cw*0602, rs2073048, and rs13437088 were all included in a logistic regression model, each of them was significantly associated with disease (p = 3 x 10(-47), 6 x 10(-8), and 3 x 10(-7), respectively). Both putative loci were also significantly associated in the Han Chinese samples after controlling for the imputed HLA-Cw*0602. A detailed analysis of HLA-B in both populations demonstrated that HLA-B*57 was associated with an increased risk of psoriasis and HLA-B*40 a decreased risk, independently of HLA-Cw*0602 and the C6orf10 locus, suggesting the potential pathogenic involvement of HLA-B. These results demonstrate that there are at least two additional loci within the MHC conferring risk of psoriasis.
Feng
Bing-Jian
BJ
Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, USA.
Sun
Liang-Dan
LD
Soltani-Arabshahi
Razieh
R
Bowcock
Anne M
AM
Nair
Rajan P
RP
Stuart
Philip
P
Elder
James T
JT
Schrodi
Steven J
SJ
Begovich
Ann B
AB
Abecasis
Gonçalo R
GR
Zhang
Xue-Jun
XJ
Callis-Duffin
Kristina P
KP
Krueger
Gerald G
GG
Goldgar
David E
DE
D000328:Adult; D044466:Asian People / Q000208:ethnology / Q000235:genetics; D016022:Case-Control Studies; D005260:Female; D055106:Genome-Wide Association Study; D015235:HLA-B Antigens / Q000235:genetics*; D059947:HLA-B40 Antigen; D015236:HLA-C Antigens / Q000235:genetics*; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000208:ethnology / Q000235:genetics*; D055815:Young Adult
D015235:HLA-B Antigens; D059947:HLA-B40 Antigen; C103707:HLA-B57 antigen; D015236:HLA-C Antigens; C491620:HLA-C*06:02 antigen
Am J Hum Genet. 2000 Jun;66(6):1833-44
10801386
Am J Hum Genet. 2005 Mar;76(3):449-62
15700229
Exp Dermatol. 2003 Aug;12(4):435-44
12930300
Am J Hum Genet. 2006 May;78(5):827-851
16642438
Chin Med Sci J. 1999 Jun;14(2):70
12901611
Am J Hum Genet. 2005 Jan;76(1):164-71
15529278
Br J Dermatol. 1978 Mar;98(3):287-92
147699
N Engl J Med. 2005 May 5;352(18):1899-912
15872205
J Invest Dermatol. 2000 Nov;115(5):824-8
11069619
J Rheumatol. 2008 May;35(5):891-5
18381784
Swiss Med Wkly. 2003 Oct 11;133(39-40):541-3
14655055
Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii37-9; discussion ii40-1
15708933
J Biol Chem. 2005 May 13;280(19):18973-80
15722350
Nat Genet. 2009 Feb;41(2):199-204
19169254
Lancet. 2007 Jul 21;370(9583):263-271
17658397
Eur J Dermatol. 2006 Sep-Oct;16(5):523-9
17101473
Nat Genet. 2009 Feb;41(2):205-10
19169255
Am J Hum Genet. 2001 Apr;68(4):978-89
11254454
J Invest Dermatol. 2005 Mar;124(3):545-52
15737195
Hum Mol Genet. 1999 Nov;8(12):2165-70
10545595
Arch Dermatol Res. 2002 May;294(3):127-30
12029499
J Invest Dermatol. 1996 Apr;106(4):711-4
8618009
Genes Immun. 2006 Sep;7(6):450-67
16791278
Tissue Antigens. 1999 Feb;53(2):135-46
10090613
Am J Hum Genet. 2005 Apr;76(4):634-46
15747258
Nature. 2007 Feb 22;445(7130):866-73
17314973
Am J Hum Genet. 2007 Feb;80(2):273-90
17236132
J Invest Dermatol. 2005 Nov;125(5):928-32
16297191
Genet Epidemiol. 2007 May;31(4):348-57
17323369
Clin Exp Immunol. 2004 Oct;138(1):83-93
15373909
Hum Genet. 2005 Dec;118(3-4):466-76
16235096
Int J Dermatol. 2004 Mar;43(3):181-7
15009387
Int J Immunogenet. 2008 Jun;35(3):179-92
18397301
Bioinformatics. 2005 Jan 15;21(2):263-5
15297300
Br J Dermatol. 2007 Jul;157(1):165-7
17553030
Biometrics. 1999 Dec;55(4):997-1004
11315092
Nature. 2007 Oct 18;449(7164):851-61
17943122
PLoS One. 2008 May 28;3(5):e2270
18509540
Br J Dermatol. 1998 Dec;139(6):978-83
9990359
Br J Dermatol. 2003 Feb;148(2):233-5
12588373
J Invest Dermatol. 1999 Sep;113(3):322-8
10469328
Am J Hum Genet. 2007 Sep;81(3):559-75
17701901
Nat Genet. 2006 Oct;38(10):1166-72
16998491
Dermatol Clin. 2004 Oct;22(4):339-47, vii
15450331
J Invest Dermatol. 2007 Aug;127(8):1886-92
17446901
J Invest Dermatol. 2007 Jan;127(1):163-9
16858420
PLoS Genet. 2008 Mar 21;4(3):e1000038
18369457
Tissue Antigens. 1998 Jun;51(6):618-22
9694354